JOIN OUR COMMUNITY

Europe

View All
Just a note about how AI is changing journalism
August 26, 2026 0

Just a note about how AI is changing journalism

By Dino Mustafić

Just a note about how AI is changing journalism

How mid-tier CDMOs are catching up

How mid-tier CDMOs are catching up

August 26, 2026 0
Who decides in the EU?

Who decides in the EU?

August 19, 2026 Off

USA

View All
Ordering a vaccine that doesn’t exist?
August 26, 2026 0

Ordering a vaccine that doesn’t exist?

By Dino Mustafić

Washington ordered a vaccine that doesn't exist. Here's what it would actually take to build it. Trump's MMR executive order is being covered as a political story. The more consequential...

The anti-vaxxers who voted for Trump are now watching him mandate vaccines

The anti-vaxxers who voted for Trump are now watching him mandate vaccines

August 26, 2026 1
Light instead of antibiotics: Ondine’s Phase 3 trial is weeks away from results that could reshape surgical infection prevention

Light instead of antibiotics: Ondine’s Phase 3 trial is weeks away from results that could reshape surgical infection prevention

March 11, 2026 Off

My Pharmaceutical

View All
Just a note about how AI is changing journalism
August 26, 2026 0

Just a note about how AI is changing journalism

By Dino Mustafić

Just a note about how AI is changing journalism

The anti-vaxxers who voted for Trump are now watching him mandate vaccines
August 26, 2026 1

The anti-vaxxers who voted for Trump are now watching him mandate vaccines

By Dino Mustafić

The movement that spent years insisting vaccines were dangerous, unnecessary, and a tool of government overreach just got an unusual...

Who decides in the EU?
August 19, 2026 Off

Who decides in the EU?

By Dino Mustafić

Out of five Croatians in Brussels, roughly one in five Croatians decided who would speak for the other four in...




Ordering a vaccine that doesn’t exist?
August 26, 2026 0

Ordering a vaccine that doesn’t exist?

By Dino Mustafić

Washington ordered a vaccine that doesn’t exist. Here’s what it would actually take to build it.

Trump’s MMR executive order is being covered as a political story. The more consequential question is a manufacturing one — and the answer from the only company that matters is: ten years, maybe more.

Poolbeg doses first patient in its CRS prevention trial, but the real test is n=30
July 13, 2026 Off

Poolbeg doses first patient in its CRS prevention trial, but the real test is n=30

By Dino Mustafić

Poolbeg Pharma (AIM: POLB) said on 13 July that the first patient has been dosed in its POLB 001 TOPICAL trial, according to the company’s RNS statement, and that University College London Hospital has now also been activated as a clinical trial site, with additional sites expected to open imminently. Investor reaction will hinge less on the milestone itself — dosing a first patient is table stakes for any trial — and more on what happens over the next six to eight weeks, since interim data is still on track for late summer.